{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bordetella pertussis : Questions médicales les plus fréquentes",
"headline": "Bordetella pertussis : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bordetella pertussis : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-10",
"dateModified": "2025-03-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bordetella pertussis"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Bordetella",
"url": "https://questionsmedicales.fr/mesh/D001884",
"about": {
"@type": "MedicalCondition",
"name": "Bordetella",
"code": {
"@type": "MedicalCode",
"code": "D001884",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.344.425"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Bordetella pertussis",
"alternateName": "Bordetella pertussis",
"code": {
"@type": "MedicalCode",
"code": "D001886",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nao Otsuka",
"url": "https://questionsmedicales.fr/author/Nao%20Otsuka",
"affiliation": {
"@type": "Organization",
"name": "Department of Bacteriology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan. notsuka@niid.go.jp."
}
},
{
"@type": "Person",
"name": "Kazunari Kamachi",
"url": "https://questionsmedicales.fr/author/Kazunari%20Kamachi",
"affiliation": {
"@type": "Organization",
"name": "Department of Bacteriology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan."
}
},
{
"@type": "Person",
"name": "Camille Locht",
"url": "https://questionsmedicales.fr/author/Camille%20Locht",
"affiliation": {
"@type": "Organization",
"name": "Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL-Centre for Infection and Immunity of Lille, F-59000 Lille, France."
}
},
{
"@type": "Person",
"name": "Kentaro Koide",
"url": "https://questionsmedicales.fr/author/Kentaro%20Koide",
"affiliation": {
"@type": "Organization",
"name": "Department of Bacteriology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan."
}
},
{
"@type": "Person",
"name": "Nicole Guiso",
"url": "https://questionsmedicales.fr/author/Nicole%20Guiso",
"affiliation": {
"@type": "Organization",
"name": "Institut Pasteur, Center for Translational Research, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Category-specific and category-general neural codes of recognition memory in the ventral visual pathway.",
"datePublished": "2023-04-29",
"url": "https://questionsmedicales.fr/article/37207411",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cortex.2023.04.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "The features analysis of hemoglobin expression on visual information transmission pathway in early stage of Alzheimer's disease.",
"datePublished": "2024-07-08",
"url": "https://questionsmedicales.fr/article/38972885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-64099-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing.",
"datePublished": "2024-01-26",
"url": "https://questionsmedicales.fr/article/38309185",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nicl.2024.103570"
}
},
{
"@type": "ScholarlyArticle",
"name": "Causal effect of COVID-19 on optic nerve and visual pathway disorders: genetic evidence of lung-brain axis.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39081310",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1440262"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retinal structure and visual pathway function at school age in children born extremely preterm: a population-based study.",
"datePublished": "2023-07-01",
"url": "https://questionsmedicales.fr/article/37393251",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12886-023-03055-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Betaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020562"
},
{
"@type": "ListItem",
"position": 5,
"name": "Burkholderiales",
"item": "https://questionsmedicales.fr/mesh/D000073556"
},
{
"@type": "ListItem",
"position": 6,
"name": "Alcaligenaceae",
"item": "https://questionsmedicales.fr/mesh/D042401"
},
{
"@type": "ListItem",
"position": 7,
"name": "Bordetella",
"item": "https://questionsmedicales.fr/mesh/D001884"
},
{
"@type": "ListItem",
"position": 8,
"name": "Bordetella pertussis",
"item": "https://questionsmedicales.fr/mesh/D001886"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bordetella pertussis - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bordetella pertussis",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bordetella pertussis",
"description": "Comment diagnostiquer la coqueluche ?\nQuels tests sont utilisés pour la coqueluche ?\nQuels sont les signes cliniques de la coqueluche ?\nQuand faire un test de coqueluche ?\nLa coqueluche peut-elle être confondue avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D001886?mesh_terms=Visual+Pathways&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bordetella pertussis",
"description": "Quels sont les premiers symptômes de la coqueluche ?\nComment se manifeste la toux dans la coqueluche ?\nLa coqueluche cause-t-elle des vomissements ?\nLes symptômes de la coqueluche varient-ils selon l'âge ?\nLa coqueluche provoque-t-elle de la fatigue ?",
"url": "https://questionsmedicales.fr/mesh/D001886?mesh_terms=Visual+Pathways&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bordetella pertussis",
"description": "Comment prévenir la coqueluche ?\nÀ quel âge vacciner contre la coqueluche ?\nLes adultes doivent-ils se faire vacciner ?\nQuelles mesures d'hygiène sont recommandées ?\nLa coqueluche est-elle contagieuse ?",
"url": "https://questionsmedicales.fr/mesh/D001886?mesh_terms=Visual+Pathways&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bordetella pertussis",
"description": "Quel est le traitement principal de la coqueluche ?\nLes antibiotiques sont-ils efficaces contre la coqueluche ?\nDes traitements symptomatiques existent-ils ?\nQuand commencer le traitement antibiotique ?\nLa vaccination aide-t-elle au traitement ?",
"url": "https://questionsmedicales.fr/mesh/D001886?mesh_terms=Visual+Pathways&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bordetella pertussis",
"description": "Quelles sont les complications possibles de la coqueluche ?\nLa coqueluche peut-elle être mortelle ?\nComment la coqueluche affecte-t-elle les nourrissons ?\nLes complications sont-elles fréquentes ?\nLa coqueluche peut-elle entraîner des problèmes respiratoires à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D001886?mesh_terms=Visual+Pathways&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bordetella pertussis",
"description": "Qui est le plus à risque de coqueluche ?\nLes personnes immunodéprimées sont-elles à risque ?\nLe manque de vaccination augmente-t-il le risque ?\nLes femmes enceintes doivent-elles se faire vacciner ?\nLes épidémies de coqueluche sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D001886?mesh_terms=Visual+Pathways&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la coqueluche ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par un prélèvement nasal et un test PCR pour détecter B. pertussis."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la coqueluche ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR, culture bactérienne et sérologie sont utilisés pour diagnostiquer la coqueluche."
}
},
{
"@type": "Question",
"name": "Quels sont les signes cliniques de la coqueluche ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des quintes de toux, des vomissements et une respiration sifflante."
}
},
{
"@type": "Question",
"name": "Quand faire un test de coqueluche ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test est recommandé si des symptômes de toux persistante apparaissent, surtout chez les enfants."
}
},
{
"@type": "Question",
"name": "La coqueluche peut-elle être confondue avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres infections respiratoires comme la bronchite."
}
},
{
"@type": "Question",
"name": "Quels sont les premiers symptômes de la coqueluche ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les premiers symptômes incluent un rhume, une légère toux et de la fièvre."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la toux dans la coqueluche ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La toux est caractérisée par des quintes paroxystiques suivies d'une inspiration bruyante."
}
},
{
"@type": "Question",
"name": "La coqueluche cause-t-elle des vomissements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements peuvent survenir après des quintes de toux intenses."
}
},
{
"@type": "Question",
"name": "Les symptômes de la coqueluche varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les nourrissons peuvent avoir des symptômes plus graves que les adultes."
}
},
{
"@type": "Question",
"name": "La coqueluche provoque-t-elle de la fatigue ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue est fréquente en raison des efforts liés aux quintes de toux."
}
},
{
"@type": "Question",
"name": "Comment prévenir la coqueluche ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la vaccination et l'hygiène respiratoire."
}
},
{
"@type": "Question",
"name": "À quel âge vacciner contre la coqueluche ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est recommandée dès l'âge de 2 mois, avec des rappels ultérieurs."
}
},
{
"@type": "Question",
"name": "Les adultes doivent-ils se faire vacciner ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les adultes doivent recevoir un rappel pour protéger les nourrissons."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains fréquemment et éviter le contact avec les personnes malades."
}
},
{
"@type": "Question",
"name": "La coqueluche est-elle contagieuse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la coqueluche est très contagieuse, surtout dans les premières semaines."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de la coqueluche ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'administration d'antibiotiques comme l'azithromycine."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre la coqueluche ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antibiotiques réduisent la durée de la maladie et la contagiosité."
}
},
{
"@type": "Question",
"name": "Des traitements symptomatiques existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements comme les antitussifs peuvent aider à soulager la toux."
}
},
{
"@type": "Question",
"name": "Quand commencer le traitement antibiotique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement doit commencer dès que la coqueluche est suspectée pour être efficace."
}
},
{
"@type": "Question",
"name": "La vaccination aide-t-elle au traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la vaccination est préventive, mais elle ne traite pas une infection active."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la coqueluche ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, les convulsions et les lésions cérébrales."
}
},
{
"@type": "Question",
"name": "La coqueluche peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la coqueluche peut être mortelle, surtout chez les nourrissons non vaccinés."
}
},
{
"@type": "Question",
"name": "Comment la coqueluche affecte-t-elle les nourrissons ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nourrissons peuvent développer des complications graves comme l'apnée et l'hypoxie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais plus fréquentes chez les jeunes enfants."
}
},
{
"@type": "Question",
"name": "La coqueluche peut-elle entraîner des problèmes respiratoires à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des problèmes respiratoires persistants après la maladie."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de coqueluche ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nourrissons, les jeunes enfants et les adultes non vaccinés sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées courent un risque accru de complications."
}
},
{
"@type": "Question",
"name": "Le manque de vaccination augmente-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le manque de vaccination est un facteur de risque majeur pour la coqueluche."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se faire vacciner ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination pendant la grossesse protège le nourrisson après la naissance."
}
},
{
"@type": "Question",
"name": "Les épidémies de coqueluche sont-elles fréquentes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des épidémies peuvent survenir, surtout dans les populations non vaccinées."
}
}
]
}
]
}
Researchers have identified category-specific brain regions, such as the fusiform face area (FFA) and parahippocampal place area (PPA) in the ventral visual pathway, which respond preferentially to on...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized primarily by cognitive impairment. The motivation of this paper is to explore the impact of the visual information transmission p...
Impaired motion perception in schizophrenia has been associated with deficits in social-cognitive processes and with reduced activation of visual sensory regions, including the middle temporal area (M...
To investigate the potential causal association between COVID-19 exposure and optic nerve and visual pathway disorders through a two-sample bidirectional Mendelian randomization (MR) analysis, and to ...
This MR analysis utilized publicly accessible summary-level data from genome-wide association studies on COVID-19 (n=158,783) and optic nerve and visual pathway diseases (n=412,181), primarily involvi...
In the forward analysis, the inverse-variance weighted method identified a significant causal effect of COVID-19 on optic nerve and visual pathway disorders (odds ratio = 1.697, 95% confidence interva...
Our findings suggest that COVID-19 exposure may increase the risk of developing optic nerve and visual pathway disorders, supporting the lung-brain axis hypothesis. These results underscore the import...
Children born extremely preterm (gestational age < 28 weeks) show reduced visual function even without any cerebral or ophthalmological neonatal diagnosis. In this study, we aimed to assess the retina...
All children born extremely preterm from 2006-2011 (n = 65) in Central Norway were invited to participate. Thirty-six children (55%) with a median age of 13 years (range = 10-16) were examined with OC...
Participants displayed abnormal retinal structure and P100 latencies (≥ 2 SD) compared to reference populations. Moreover, there was a negative correlation between P100 latency in large checks and RNF...
Children born extremely preterm without preterm brain injury sequelae have signs of persistent immaturity of retinal vasculature and neuroretinal layers. Thinner neuroretinal layers are associated wit...
Fixel-based analysis (FBA) is a new method that overcomes the technical limitations of diffusion tensor imaging (DTI) by enabling the characterization of multiple fiber populations within a voxel, and...
In this prospective cross-sectional study, brain DTI scans which were collected with more than six uniformly distributed gradient directions and higher b‑values (up to 2000 s/mm...
Pearson's correlation analysis showed that DTI parameters of white matter (optic nerve, optic chiasma, optic tract, and optic radiation) in the optic pathway were correlated with age. FA values were n...
FBA provides a useful method to assess age-related changes in the visual pathway, which is sensitive to diffusion. In addition, the b‑value influences DTI parameters and signal-to-noise ratio of the i...
Anti-NMDA receptor (NMDAR) encephalitis patients have been reported to exhibit visual dysfunction without retinal thinning. The objective of our study was to examine the involvement of the visual path...
In this cross-sectional study, patients diagnosed with anti-NMDAR encephalitis per consensus criteria underwent postrecovery visual acuity (VA) testing and optical coherence tomography (OCT) with auto...
A total of 16 anti-NMDAR (32 eyes) and 32 HC (64 eyes) were included in the study. Anti-NMDAR exhibited lower low-contrast VA (2.5% contrast: -4.4 letters [95% CI; -8.5 to -0.3]; P = 0.04, 1.25% contr...
Although the visual system seems to be involved in anti-NMDAR encephalitis, no retinal structural or occipital cortex functional abnormalities seem to be responsible for the visual dysfunction. When d...
Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant neurodegenerative disorder characterized by progressive cerebellar ataxia associated with retinal degeneration. The disease is rare in Jap...
The size of the anterior visual pathway (AVP) structures is affected by patient age and pathology. Normative data is useful when determining whether pathology is present. AVP structures do not respect...
For each patient 32 measurements of AVP structures were obtained in 145 children (2 months - 18 years) with normal brain MR studies on high-resolution 3D T2w FSE images adjusted to the axis of each AV...
Descriptive statistics were compiled in a reference table and prediction plots in relation to age, height, and body surface area (BSA) were obtained from the best overall performing statistical model,...
Detailed charts of reference values for AVP structures as well as prediction plots in relation to age, height and BSA were established using axis-corrected measurements from the MPR of high-resolution...
Recovery of vision after acute optic neuritis (AON) is critical to improving the quality of life of people with demyelinating diseases. The objective of the study was to prospectively assess the chang...
We studied a prospective cohort of 88 consecutive patients with AON with 6-month follow-up using high and low-contrast (2.5%) visual acuity, color vision, retinal thickness from optical coherence tomo...
We found that after 6 months, low-contrast vision and quality of vision remained moderately impaired. The thickness of the ganglion cell layer at baseline was a predictor of low-contrast vision 6 mont...
The assessment of the visual pathway at baseline predicts permanent vision disability after AON, indicating that damage is produced early after disease onset and that it can be used for defining visio...